|
In people with impaired glucose tolerance (IGT) and/or impaired fasting glucose (IFG) without cardiovascular disease and diabetes, treatment with ramipril had a neutral effect on carotid intima-media thickness (CIMT), whereas rosiglitazone modestly reduced CIMT progression, according to the STARR trial results released June 2 issue in the Journal of the American College of Cardiology.
|
Ranbaxy Laboratories Limited has received approval from the FDA for its abbreviated new drug application to market and manufacture Ramipril 5-mg and 10-mg capsules.
|
RSS 
Middle age introduces itself in many ways; one is atrial fibrillation (AF). My onset of AF seems to have coincided with a mountain bike accident in the woods of North Carolina that resulted in some cracked ribs.
The use of health IT to reduce rehospitalizations will be welcome but also disruptive, said Stephen Jencks, an independent consultant in healthcare safety during a Feb. 24 webinar on the potential use of health IT to mitigate rehospitalizations, sponsored by the Agency for Healthcare Research and Quality (AHRQ).